Many gene-dosage anomalies have been previously mapped in PD patients, including familiar genes (SNCA, PARK2, PINK1, PARK7, ATP13A2) [48, 49], as well as several rare CNVs in candidate regions [45]. The gene discussed is PRKN; the disease is Parkinson disease.